A detailed history of Horizon Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Horizon Wealth Management, LLC holds 287 shares of LLY stock, worth $260,225. This represents 0.06% of its overall portfolio holdings.

Number of Shares
287
Holding current value
$260,225
% of portfolio
0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $169,961 - $227,384
287 New
287 $223,000
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $39,022 - $45,817
140 Added 9.2%
1,662 $539,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $938 - $1,166
4 Added 0.26%
1,522 $436,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $341,322 - $423,582
1,518 New
1,518 $419,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Horizon Wealth Management, LLC Portfolio

Follow Horizon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Wealth Management, LLC with notifications on news.